CNN

NeuroMetrix Reports Quell® Technology to be Used in NIH-Funded Trial Evaluating Effectiveness of Transcutaneous Electrical Nerve Stimulation (TENS) for Fibromyalgia

WOBURN, Mass., April 16, 2020 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today announced that Quell technology has been selected for use in a large, NIH-funded, randomized, pragmatic ...
Medscape

Transcutaneous Electrical Nerve Stimulation Plus Physical Therapy Helps Reduce Fibromyalgia Pain, Fatigue

CHICAGO — Adding transcutaneous electrical nerve stimulation (TENS) to outpatient physical therapy (PT) reduced movement-evoked pain (MEP) and other types of pain and fatigue for patients with ...
Seeking Alpha

NeuroMetrix to Exhibit Quell® Fibromyalgia and Present New Clinical Data at the American Academy of Pain Medicine 2023 Annual Meeting

WOBURN, Mass., March 21, 2023 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NURO) will exhibit Quell Fibromyalgia at the American Academy of Pain Medicine 39 th Annual Meeting on March 23 - 26 in Ft.
Hosted on MSN

Best TENS machines for effective chronic pain relief

As much as we’d like to tell you that pain is just the French word for bread, we know that chronic pain conditions are nothing to joke about. From slipped discs to autoimmune diseases which cause ...